参考文献/References:
[1] Wu C, Su J, Wang X, et al. Overexpression of the phospholi-pase A2 group V gene in glioma tumors is associated with poor patient prognosis [J]. Cancer Manag Res, 2019, 11: 3139-3152.
[2] 杜金龙. 长链非编码RNA DANCR在神经胶质瘤中的表达水平和临床意义[J]. 山西医科大学学报,2019,50(2):210-214.
[3] 张佩佩,曾 强,黄 宁,等. 动态对比增强MRI在脑胶质瘤分级中计算模型的选择及应用研究[J]. 中华放射学杂志,2017,49(13):1341-1344.
[4] 张立志,刘 平,吉慧军,等. 全身免疫炎症指数(SII)对胶质瘤患者临床预后的影响及与P53突变的关系[J]. 现代肿瘤医学,2018,26(24):3937-3943.
[5] 李 巍,王雅茹,宋 雯,等. 胶质瘤患者凝血指标的变化及其与胶质瘤恶性程度相关性分析[J]. 中华医学杂志,2018,98(5):336-339.
[6] Tomita M, Ayabe T, Maeda R, et al. Systemic immune-inflammation index predicts survival of patients after cura-tive resection for non-small cell lung cancer [J]. In Vivo, 2018, 32: 663-667.
[7] Perisanidis C, Psyrri A, Cohen EE, et al. Prognostic role of pretreatment plasma fbrinogen in patients with solid tumors:a systematic review and meta-analysis [J]. Cancer Treat Rev, 2015, 41: 960-970.
[8] Candido J, Hagemann T. Cancer-related inflammation [J]. J Clin Immunol, 2013, 33(S1): S79-S84.
[9] Borg N, Guilfoyle MR, Greenberg DC, et al. Serum albumin and survival in glioblastoma multiforme [J]. J Neurooncol, 2011, 105: 77-81.
[10] Ostrom QT, Bauchet L, Davis FG, et al. The epidemiology of glioma in adults: a ’state of the science’ review [J]. Neuro Oncol, 2014, 16: 896-913.
[11] Wang JL, Xiao WJ, Chen WY, et al. Prognostic significance of preoperative neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with glioma [J]. EXCLI J, 2018, 17: 505-512.
[12] Kemerdere R, Akgun MY, Toklu S, et al. Preoperativesystemic inflammatory markers in low- and high-grade gliomas: a retrospective analysis of 171 patients [J]. Heliyon, 2019, 5(5): e01681.
[13] Gao YB, Guo W, Cai SH, et al. Systemic immune-inflam-mation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma [J]. J Cancer, 2019, 10: 3188-3196.
[14] Stanger BZ, Kahn ML. Platelets and tumor cells: a new form of border control [J]. Cancer Cell, 2013, 24: 9-11.
[15] Adams GN, Rosenfeldt L, Frederick M, et al. Colon cancer growth and dissemination relies upon thrombin, stromal PAR-1, and fibrinogen [J]. Cancer Res, 2015, 75: 4235-4243.
[16] Martino MM, Briquez PS, Ranga A, et al. Heparin-binding domain of fibrin(ogen)binds growth factors and promotes tissue repair when incorporated within a synthetic matrix [J]. Proc Natl Acad Sci USA, 2013, 110(12): 4563-4568.
[17] 郝 玮,郭彩虹,李 莉,等. 老年非小细胞肺癌患者血浆D-二聚体与纤维蛋白原的临床意义及其与化疗的关系[J]. 国际检验医学杂志,2015,36(23):3472-3475.
[18] 李生平,周业江. 手术前后白蛋白与球蛋白比值变化对结肠癌预后的评估价值[J]. 实用医学杂志,2019,35(5):783-388.
[19] 范仕兵,冉住国,李 骥,等. 术前血清白蛋白与球蛋白比值与脑胶质母细胞瘤预后的相关性[J]. 中国神经精神疾病杂志,2018,44(7):412-418.
[20] 张海茂,赵风雪,田可港,等. 急性白血病患者血浆D-二聚体、血管性血友病因子、抗凝血酶Ⅲ、纤维蛋白原水平表达及意义[J]. 国际检验医学杂志,2018,39(17):2126-2130.
相似文献/References:
[1]付 锴 江普查 宫 睿 王 伟.表达VASH1基因的人脑胶质瘤U-87MG细胞对化疗药物敏感性的变化[J].中国临床神经外科杂志,2016,(01):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
FU Kai,JIANG Pu-cha,GONG Rui,et al.Effect of lentiviral vector-mediated VASH1 gene on chemosensitivity of human glioma U-87MG cells[J].,2016,(04):34.[doi:10.13798/j.issn.1009-153X.2016.01.012]
[2]崔焕喜,柳 琛.多模态MRI、神经导航和超声在脑胶质瘤术中的应用[J].中国临床神经外科杂志,2016,(11):721.[doi:10.13798/j.issn.1009-153X.2016.11.027]
[3]闫 珊 徐善才.多学科护理照顾模式对脑胶质瘤术后病人自我护理能力的影响[J].中国临床神经外科杂志,2017,(05):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
YAN Shan,XU Shan-cai..Effects of multi-subjects nursing care model on self-care ability in patients with brain glioma after operation[J].,2017,(04):352.[doi:10.13798/j.issn.1009-153X.2017.05.026]
[4]罗似亮 夏之柏.脑胶质瘤病人脑脊液Midkine表达的临床意义[J].中国临床神经外科杂志,2017,(06):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
LUO Si-liang,XIA Zhi-bo..Clinical meanings of midkine expression in cerebrospinal fluid of patients with gliomas[J].,2017,(04):416.[doi:10.13798/j.issn.1009-153X.2017.06.017]
[5]呼铁民 褚会松 田 甜 王昆鹏 杨国军 杨立军 王维兴.脑胶质瘤ADAM17与EGFR的表达及临床意义[J].中国临床神经外科杂志,2017,(08):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
HU Tie-min,CHU Hui-song,TIAN Tian,et al.Expressions of ADAM17 and EGFR in gliomas tissues and their clinical meanings[J].,2017,(04):557.[doi:10.13798/j.issn.1009-153X.2017.08.012]
[6]汪超甲 综述 王 辉 审校.脑胶质瘤化疗现状及耐药机制的研究进展[J].中国临床神经外科杂志,2017,(11):791.[doi:10.13798/j.issn.1009-153X.2017.11.023]
[7]高剑峰 姚庆和 李晓辉 龙宇波 陈振波.脑胶质瘤miR-9、PPARγ表达水平及临床意义[J].中国临床神经外科杂志,2018,(01):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
GAO Jian-feng,YAO Qing-he,LI Xiao-hui,et al.Expressions of miR-9 and PPARγ in human brain gliomas and their clinical meanings[J].,2018,(04):17.[doi:10.13798/j.issn.1009-153X.2018.01.006]
[8]刘 靖 吴立权 黄书岚.聚焦解决模式对脑胶质瘤术后病人自我管理效能感及生命意义的影响[J].中国临床神经外科杂志,2018,(03):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
LIU Jing,WU Li-quan,HUANG Shu-lan..Effects of solution focused intervention on self-management efficacy and meanings of life in the patients with gliomas after surgery[J].,2018,(04):208.[doi:10.13798/j.issn.1009-153X.2018.03.025]
[9]刘 炎 杭春华.脑胶质瘤卒中误诊为脑动静脉畸形并出血1例[J].中国临床神经外科杂志,2018,(06):448.[doi:10.13798/j.issn.1009-153X.2018.06.025]
[10]刘东明 胡新华 刘 永 陈 玖 刘宏毅.脑胶质瘤病人静息态默认模式网络研究进展[J].中国临床神经外科杂志,2018,(12):821.[doi:10.13798/j.issn.1009-153X.2018.12.022]